11. Characterizing compensated cirrhosis (CC) patients with potential etiology of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH): findings from large Italian administrative databases. (February 2019) Authors: Marchesini, G.; Ting, J.; Saragoni, S.; Perrone, V.; Shreay, S.; Petta, S. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Chronic Intermittent Hypoxia is associated with Liver Damage and Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease. (15th February 2015) Authors: Petta, S.; Marrone, O.; Torres, D.; Buttacavoli, M.; Cammà, C.; Di Marco, V.; Licata, A.; Bue, A. Lo; Parrinello, G.; Pinto, A.; Selvaggio, A.; Tuttolomondo, A.; Craxì, A.; Bonsignore, M. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study. (15th February 2015) Authors: Piscaglia, F.; Baroni, G. Svegliati; Barchetti, A.; Pecorelli, A.; Marinelli, S.; Tiribelli, C.; Bellentani, S.; Bolondi, L.; Zoli, M.; Malagotti, D.; Brandi, G.; Bugianesi, E.; Vanni, E.; Mezzabotta, L.; Cabibbo, G.; Petta, S.; Fracanzani, A.; Fargion, S.; Marra, F.; Fani, B. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Current epidemiology of HCV in Sicily: the RESIST-HCV model. (October 2019) Authors: Di Marco, V.; Cartabellotta, F.; Mazzucco, W.; Calvaruso, V.; Petta, S.; Mazzola, S.; Cusimano, R.; Amodio, R.; Scifo, G.; Russello, M.; Cacopardo, B.; Squadrito, G.; Raimondo, G.; Pollicino, T.; Ceccherini-Silbertein, F.; Vitale, F.; Cammà, C.; Craxì, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 3 Page Start: e262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients. (February 2019) Authors: Cabibbo, G.; Celsa, C.; Calvaruso, V.; Petta, S.; Cacciola, I.; Cannavò, M.R.; Madonia, S.; Rossi, M.; Magro, B.; Rini, F.; Distefano, M.; Larocca, L.; Prestileo, T.; Malizia, G.; Bertino, G.; Benanti, F.; Licata, A.; Scalisi, I.; Mazzola, G.; Di Rosolini, M.A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort. Issue 1 (February 2018) Authors: Calvaruso, V.; Petta, S.; Cacciola, I.; Cabibbo, G.; Cartabellotta, F.; Di Rosolini, A.; Davì, A.; Cannavò, M.; Russello, M.; Distefano, M.; Scifo, G.; Di Lorenzo, F.; Prestileo, T.; La Rocca, L.; Montineri, A.; Fiduli, G.; Digiacomo, A.; Cannizzaro, M.; Madonia, S.; Licata, A. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs). Issue 1 (16th February 2017) Authors: Calvaruso, V.; Cabibbo, G.; Cacciola, I.; Petta, S.; Madonia, S.; Bellia, A.; Tinè, F.; Distefano, M.; Giannitrapani, L.; Prestileo, T.; Mazzola, G.; Davì, A.; Larocca, L.; Ardiri, A.; Digiacomo, A.; Gussio, M.; Guarneri, L.; Magro, A.; Averna, A.; Iacobello, C. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Effects of HCV eradication by DAA on oxidative stress parameters in patients with chronic hepatitis C. (February 2019) Authors: Salomone, F.; Petta, S.; Distefano, A.; Calvaruso, V.; Castracane, C.C.; Grimaudo, S.; Pipitone, R.; Rini, F.; Galvano, F.; Di Marco, V.; Craxì, A.; Volti, G. Li Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with mild-moderate fibrosis, with or without glucose abnormalities: interim results of the EGG18 study. (February 2020) Authors: Calvaruso, V.; Petta, S.; Ferraro, D.; La Mantia, C.; Reina, G.; Zarcone, A.; Assanto, E.; Di Marco, V.; Craxì, A. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Efficacy of oral direct acting antivirals for treatment of advanced chronic hepatitis or compensated cirrhosis due to hepatitis C virus infection: The real-life experience of the Sicily registry. Issue 1 (16th February 2017) Authors: Cacciola, I.; Petta, S.; Distefano, M.; Cannavò, M.R.; Davì, A.; Madonia, S.; Calvaruso, V.; Larocca, L.; Di Lorenzo, F.; Digiacomo, A.; Bertino, G.; Licata, A.; Latteri, F.; Benanti, F.; Volpes, R.; Guarneri, L.; Averna, A.; Scalisi, I.; Iacobello, C.; Colletti, P. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗